|Trade names||Superlutin, Antigest|
|Synonyms||Superlutin; Superlutine; MMA; Methylenedehydroacetoxyprogesterone; MDAP; 17α-Hydroxy-16-methylene-δ6-progesterone 17α-acetate; 17α-Acetoxy-16-methylenepregna-4,6-diene-3,20-dione|
|Drug class||Progestogen; Progestin; Progestogen ester|
|Chemical and physical data|
|Molar mass||382.5 g/mol g·mol−1|
|3D model (JSmol)|
Methenmadinone acetate (MMA), also known as methylenedehydroacetoxyprogesterone (MDAP) and sold under the brand names Superlutin and Antigest, is a progestin medication which was developed in Czechoslovakia in the 1960s. It is the C17α acetate ester of methenmadinone.
Analogues of methenmadinone acetate include methenmadinone caproate (MMC), which was studied in combination with estradiol valerate as a combined injectable contraceptive (tentative brand name Lutofollin); chlormethenmadinone acetate (chlorsuperlutin; SCH-12600; 6-chloro-MMA), which has been used in combination with mestranol in birth control pills (brand names Biogest, Sterolibrin, Antigest B) and in veterinary medicine (brand name Agelin); bromethenmadinone acetate (bromsuperlutin; 6-bromo-MMA), which was assessed but was never marketed; and melengestrol acetate (methylsuperlutin; 6-methyl-MMA), which is used in veterinary medicine.
|This article about a steroid is a stub. You can help Wikipedia by expanding it.|
|This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.|